Identification and validation of urinary CXCL9 as a biomarker for diagnosis of acute interstitial nephritisDennis G. Moledina, Chirag R. Parikh, Wassim Obeid et al.|Journal of Clinical Investigation|2023Cited by 73
Rationale and Design of a Phase 2, Double-blind, Placebo-Controlled, Randomized Trial Evaluating AMP Kinase-Activation by Metformin in Focal Segmental GlomerulosclerosisGabriel Barsotti, Madhav C. Menon, Vijayakumar R. Kakade et al.|Kidney International Reports|2024Cited by 3